1,715 results on '"Chen, Zhe-Sheng"'
Search Results
102. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function
103. Long noncoding RNAs have pivotal roles in chemoresistance of acute myeloid leukemia
104. Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
105. The role of androgen therapy in prostate cancer: from testosterone replacement therapy to bipolar androgen therapy
106. Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
107. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities
108. Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity
109. Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells
110. Research progress of traditional Chinese medicine influencing macrophage polarization
111. Therapeutic strategies to overcome taxane resistance in cancer
112. The emerging nature of Ubiquitin-specific protease 7 (USP7): a new target in cancer therapy
113. Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance
114. Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
115. Chloroquine against malaria, cancers and viral diseases
116. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
117. Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
118. MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
119. Correction to: Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
120. Drug resistance: from bacteria to cancer
121. The combination of disulfiram and copper for cancer treatment
122. Recent progress in antitumor functions of the intracellular antibodies
123. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
124. A multi-functionalized nanocomposite constructed by gold nanorod core with triple-layer coating to combat multidrug resistant colorectal cancer
125. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
126. Reassessing specificity/selectivity of taxane-based chemotherapy
127. Protective effects of Salvianic acid A against multiple-organ ischemia-reperfusion injury: a review
128. Behind the Indolent Facade: Uncovering the Molecular Features and Malignancy Potential in Lung Minimally Invasive Adenocarcinoma by Single‐Cell Transcriptomics
129. Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDR
130. AR/RKIP pathway mediates the inhibitory effects of icariin on renal fibrosis and endothelial-to-mesenchymal transition in type 2 diabetic nephropathy
131. Ligands and receptors in human cytomegalovirus entry: current therapies and new directions
132. Overexpression of ABCC1 and ABCG2 Confers Resistance to Talazoparib, a Poly (ADP-Ribose) Polymerase Inhibitor
133. Chemical composition, biological activities, and quality standards of hawthorn leaves used in traditional Chinese medicine: a comprehensive review
134. Dostarlimab in the treatment of mismatch repair deficient recurrent or advanced endometrial cancer
135. Editorial: Tumor microenvironment and cancer therapy
136. Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations
137. Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance
138. Revisiting mTOR inhibitors as anticancer agents
139. Modulating ROS to overcome multidrug resistance in cancer
140. Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance.
141. Darovasertib, a novel treatment for metastatic uveal melanoma
142. The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells
143. Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
144. Advances in receptor chromatography for drug discovery and drug–receptor interaction studies
145. Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization
146. Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors
147. Patterned synthesis of ZnO nanorod arrays for nanoplasmonic waveguide applications
148. Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance
149. Characterization of a novel HDAC/RXR/HtrA1 signaling axis as a novel target to overcome cisplatin resistance in human non-small cell lung cancer
150. Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.